Stratus, the nation’s leading provider of EEG services, is proud to announce that its Chief Medical Officer (CMO), Jeremy Slater, MD, FAAN, FAES, FACNS, has been designated as a Fellow of the American Epilepsy Society (AES) and has been awarded Fellow Member status with the American Clinical Neurophysiology Society (ACNS). Dr. Slater oversees Stratus’ delivery of clinical care and quality initiatives, as well as heads the company’s MERLN division.
Dr. Slater has devoted his career to advancing the field of epilepsy, including providing more than 27 years of clinical care for patients with seizures. His accomplishments include being the former Director of the Texas Comprehensive Epilepsy Program in Houston, Texas and being one of the lead clinical investigators for vagal nerve stimulation (VNS) therapy. Recognition as an AES Fellow acknowledges a physician’s professional accomplishments and dedication in the field of epilepsy. It is a way that AES members recognize peers who have made especially meaningful contributions through research, clinical or academic achievement, volunteerism, and/or leadership. ACNS Fellow status acknowledges a strong commitment to the Society and the field of Clinical Neurophysiology, demonstrated by loyal membership as well as frequent active participation in Society meetings.
“We’re proud of the work that Dr. Slater does in his role at Stratus and in also continuing to provide direct care of patients with epilepsy. We congratulate him and are glad that both AES and ACNS have recognized his dedication,” said Charlie Alvarez, Chief Executive Officer at Stratus. Dr. Slater has been with Stratus since 2018 and started Stratus’ research and development division, MERLN, which focuses on the developing field of artificial intelligence in clinical neurophysiology. His work in this area further solidifies his dedication and commitment to helping improve the care of people with epilepsy.
To learn more about Dr. Slater’s work and Stratus visit http://www.stratusneuro.com.
Stratus is the nation’s leading provider of ambulatory in-home video EEG and has served more than 80,000 patients across the U.S. The company offers technology, services, and proprietary software solutions to help neurologists accurately and quickly diagnose their patients with epilepsy and other seizure-like disorders. Stratus also provides mobile cardiac telemetry to support the diagnostic testing needs of the neurology community. Additionally, the company’s R&D division holds the world’s largest database of de-identified EEG recordings and is applying machine learning to improve the overall quality and efficiency of EEG testing. To learn more, visit http://www.stratusneuro.com.